跳至主要内容
临床试验/NCT03278145
NCT03278145Unknown不适用

Dependence Receptors in Childhood Acute Leukemia

Hospices Civils de Lyon1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2017年11月最近更新:
适应症

试验速览

阶段
不适用
入组人数
30
试验地点
1
主要终点
Detection of specific labeling of the DCC-dependent receptor on the surface of leukemic cells

研究概览

简要总结

Acute leukaemias (AL) are the first cause of cancer in children, with a majority of B acute lymphoblastic leukemia (ALL). Some of the processes causing leukemogenesis are already identified and well characterized in some AL subtypes such as translocation t (12; 21) of good prognosis in ALL. However, translocations are not sufficient to explain all the different processes of leukemogenesis, and other processes such as genetic / epigenetic mutations leading to oncogene activation / inhibition of tumor suppressor genes are the object research. Among the latter, mutations in tumor suppressor genes such as DCC (Deleted in Colorectal Cancer) have recently been identified in solid cancers, such as in hemopathies. This gene was subsequently characterized as encoding a "dependence receptor" specifically binding to its Netrin-1 ligand.

Dependence receptors (RDs) are transmembrane receptors that cause cell death in the absence of their ligand. RD decreases tumor progression and overexpression of their ligands is observed in many cancers, such as B lymphomatous hemopathies in adults. Inhibition of the RD-ligand interaction constitutes a new and original therapeutic target in oncology.

The aim of this study is to investigate whether RDs, in particular DCC, are expressed in acute leukemia cells at the time of diagnosis or relapse in patients aged 1 to 18 years, and then in these patients at the time of the remission balance. This research will be both qualitative and quantitative.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
1 Year 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • aged between 1 and 18 years
  • taken care of at the Institute of Hematology and Pediatric Oncology (Service of Professor Yves Bertrand, IHOPe)
  • for acute lymphoblastic or myeloblastic leukemia
  • initial diagnosis or relapse
  • who do not have a vital emergency criterion at the time of taking care (see exclusion criteria)
  • affiliated to a social security scheme (100% assumed)
  • after signing the informed consent of the holders of parental authority

排除标准

  • less than 1 year, or more than 18 years to diagnosis
  • with chronic leukemia
  • severe anemia at diagnosis (hemoglobin <40g / l), or a state of shock whatever the cause (infectious, cardiogenic, hypovolemic)

结局指标

主要结局

Detection of specific labeling of the DCC-dependent receptor on the surface of leukemic cells

时间窗: Maximum 4 months (sampling at the time of diagnosis / relapse and remission)

Primary endpoint: presence of specific labeling of the DCC-dependent receptor on the surface of leukemic cells that will be detectable in flow cytometry. This marking will be both qualitative (positive signal = presence of the receptor, absence of signal = absence of the receptor), and quantitative (percentage of expression of the receptor on the surface of the cells).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验